SCHEMBL8233137

SCHEMBL8233137

CC1=C(c2ccc(NC(=O)c3ccncc3C)cc2)CN(C(=O)Oc2ccc([N+](=O)[O-])cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
AURKA O14965 2/20 0.40
MAPT P10636 5/20 0.39
KMT2A Q03164 5/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
MEN1 O00255 4/20 0.39
FAAH O00519 3/20 0.39
TRPV1 Q8NER1 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
POLB P06746 2/20 0.37
THRB P10828 1/20 0.37
MITF O75030 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988297 0.92 STIM1 (0.45) ALDH1A1SMN1; SMN2AURKAMAPTKMT2A
SCHEMBL987652 0.85 LMNA (0.41) SMN1; SMN2LMNA
SCHEMBL987687 0.83 MAPT (0.41) ALDH1A1SMN1; SMN2MAPTKMT2ARAB9A
SCHEMBL10104881 0.81 MAPT (0.40) ALDH1A1SMN1; SMN2MAPTKMT2ARAB9A
SCHEMBL8232807 0.80 ERN1 (0.41) MAPTLMNAPOLBPTPN11
SCHEMBL987057 0.78 CYP2D6 (0.41) RAB9ACYP2D6POLBPTPN11
SCHEMBL986498 0.76 STIM1 (0.50) RAB9ANPC1LMNA
SCHEMBL986996 0.74 TYK2 (0.39) ALDH1A1SMN1; SMN2MAPTKMT2ARAB9A
SCHEMBL8228702 0.73 PDGFRB (0.39) ALDH1A1SMN1; SMN2MAPTKMT2ARAB9A
SCHEMBL987577 0.73 NAMPT (0.39) ALDH1A1SMN1; SMN2MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087443-A2 VINYL-PHENYL DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-08-02 WO disclosed